Chinese biotech firm Immorna raises $100m in extended Series A rounds

Chinese biotech firm Immorna raises $100m in extended Series A rounds

Photo by National Cancer Institute on Unsplash

27 February, 2023

Edited by: Padma Priya

Printed by Unregistered user on Mon, 08 Dec 2025 13:24:09 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Chinese biotech firm Genecast refiles for Hong Kong IPO

Is China's AI-driven drug discovery sector ready to take on global centrestage?

Read more from Greater China

IDG, others pour over $141m into Chinese new materials maker Xingi

Venture Capital

China’s Fudan University sets up $100m fund for early-stage startups